TapewireFind a company

person · Reporting owner

Gasser Elizabeth Anne

Disclosed activity across 1 company

Tapewire entity
22300
SEC CIK
0001866283

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TANDEM DIABETES CARE INCTNDM · Entity 4682EVP, Chief Strategy OfficerAugust 15, 2026August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TANDEM DIABETES CARE INC

Report date August 15, 2026 · Filed August 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,396 Ending reported balance After 2026-08-15 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2026-08-15 · Exercise / conversion · Acquired 1,097 · Balance 1,097

Row 2 · 2026-08-15 · Tax withholding · Disposed 589 · Balance 508

F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.

Row 3 · 2026-08-15 · Exercise / conversion · Acquired 1,917 · Balance 2,425

Row 4 · 2026-08-15 · Tax withholding · Disposed 1,029 · Balance 1,396

F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect3,290 Reported balance After 2026-08-15 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2026-08-15 · Exercise / conversion · Disposed 1,097 · Balance 3,290

F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect13,418 Reported balance After 2026-08-15 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2026-08-15 · Exercise / conversion · Disposed 1,917 · Balance 13,418

F6: Awarded on May 30, 2025 pursuant to the 2023 Plan.

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

Common StockSEC Table I · non-derivativeIndirectSee Footnote33,109 Reported balance Holding disclosure · report date 2026-08-15 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 33,109

F2: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.

F2: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.

F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).

F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

F6: Awarded on May 30, 2025 pursuant to the 2023 Plan.

F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · derivative · entry 8

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 2,146 $47.37 $101,656.02
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 7

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,510

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 6,012 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,656

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 170 $47.37 $8,052.90
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,644

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 58 $47.37 $2,747.46
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,340

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,398

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:47 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantCommon Stock 813 $15.64 $12,715.32
Disclosure

SEC source: 0001438133-24-000102 · wk-form4_1715982455.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,236

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2023 through May 15, 2024. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 372 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000035 · wk-form4_1709244758.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373

Underlying: Common Stock · 372 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on May 27, 2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on May 27, 2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 130 $27.34 $3,554.20
Disclosure

SEC source: 0001438133-24-000035 · wk-form4_1709244758.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,423

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 372 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000035 · wk-form4_1709244758.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 475 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,371

Underlying: Common Stock · 475 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 812

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 195 $24.29 $4,736.55
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,181

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 475 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 67 $24.29 $1,627.43
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,901

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 15, 2024 Filed Feb 21, 2024 00:26 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-24-000012 · wk-form4_1708475192.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,968

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 745

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 129 $19.47 $2,511.63
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,805

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 27, 2023 Filed Nov 29, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000246 · wk-form4_1701292152.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,934

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · derivative · entry 7

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,846

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 975

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 164 $18.20 $2,984.80
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,561

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $18.20 $1,037.40
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,251

F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2023 Filed Nov 17, 2023 21:09 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantCommon Stock 565 $15.47 $8,740.55
Disclosure

SEC source: 0001438133-23-000226 · wk-form4_1700255367.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,146

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2023 through November 15, 2023. This transaction is also exempt under Rule 16b-3(c).

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 372 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000194 · wk-form4_1693426942.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,118

Underlying: Common Stock · 372 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 129 $27.06 $3,490.74
Disclosure

SEC source: 0001438133-23-000194 · wk-form4_1693426942.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,581

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:22 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 372 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000194 · wk-form4_1693426942.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,320

Underlying: Common Stock · 474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan, as amended, and the agreements related thereto.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,137

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 164 $28.88 $4,736.32
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,338

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 474 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $28.88 $1,646.16
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,028

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
August 15, 2023 Filed Aug 17, 2023 20:29 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000170 · wk-form4_1692304178.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:39 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000129 · wf-form4_168549717842166.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,490

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:39 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 129 $26.57 $3,427.53
Disclosure

SEC source: 0001438133-23-000129 · wf-form4_168549717842166.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,923

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 30, 2023 Filed May 31, 2023 01:39 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000129 · wf-form4_168549717842166.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,052

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2023 Filed May 31, 2023 01:39 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantPSU 2023 05 25 · Derivative 8,883 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000129 · wf-form4_168549717842166.xml · derivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,883

Underlying: Common Stock · 8,883 shares

Expires not disclosed

F2 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F5 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.exercise_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.expiration_date: Each performance stock unit (PSU) represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the Company) common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2025 (the Measurement Date). The number of shares issued may range from 0% to 200% of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

Read SEC document
May 25, 2023 Filed May 31, 2023 01:39 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 GrantRSU 2023 05 25 · Derivative 18,037 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000129 · wf-form4_168549717842166.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,037

Underlying: Common Stock · 18,037 shares

Expires not disclosed

F2 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.

F4 · derivative.exercise_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

F4 · derivative.expiration_date: RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · derivative · entry 6

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,794

Underlying: Common Stock · 1,897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · derivative · entry 5

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,299

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 656 $32.13 $21,077.28
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 4

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,679

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 1,897 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,335

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 57 $32.13 $1,831.41
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,438

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 15, 2023 Filed May 17, 2023 22:11 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 163 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000082 · wf-form4_168436148344720.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,495

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionRestricted Stock Unit · Derivative 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · derivative · entry 3

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,863

Underlying: Common Stock · 373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Tax withholdingCommon Stock 153 $35.87 $5,488.11
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 2

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,332

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 22:57 UTC TANDEM DIABETES CARE INC TNDM · Entity 4682 Exercise / conversionCommon Stock 373 $0.00 $0.00
Disclosure

SEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 1

Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.